Janus Henderson Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-84,510
Closed -$8.58M 2430
2025
Q4
$8.58M Buy
84,510
+3,000
+4% +$241K ﹤0.01% 778
2025
Q3
$4.46M Buy
81,510
+7,408
+10% +$370K ﹤0.01% 955
2025
Q2
$3.94M Buy
74,102
+60,787
+457% +$3.09M ﹤0.01% 981
2025
Q1
$581K Hold
13,315
﹤0.01% 1879
2024
Q4
$748K Hold
13,315
﹤0.01% 1827
2024
Q3
$907K Sell
13,315
-2,185
-14% -$123K ﹤0.01% 1723
2024
Q2
$655K Sell
15,500
-328
-2% -$18K ﹤0.01% 1854
2024
Q1
$1.09M Buy
15,828
+2
+0% +$127 ﹤0.01% 1593
2023
Q4
$1.17M Sell
15,826
-139
-0.9% -$9.11K ﹤0.01% 1538
2023
Q3
$1.09M Sell
15,965
-593
-4% -$50.3K ﹤0.01% 1517
2023
Q2
$1.55M Sell
16,558
-1,638
-9% -$128K ﹤0.01% 1370
2023
Q1
$1.23M Sell
18,196
-1,317
-7% -$84.7K ﹤0.01% 1514
2022
Q4
$966K Sell
19,513
-18,721
-49% -$765K ﹤0.01% 1376
2022
Q3
$1.24M Buy
38,234
+15,200
+66% +$627K ﹤0.01% 1532
2022
Q2
$908K Sell
23,034
-11,595
-33% -$620K ﹤0.01% 1382
2022
Q1
$2.42M Buy
+34,629
New +$2.53M ﹤0.01% 1174
2021
Q4
Sell
-59,466
Closed -$5.68M 2559
2021
Q3
$5.68M Sell
59,466
-1,794
-3% -$189K ﹤0.01% 1027
2021
Q2
$7.61M Buy
61,260
+1,058
+2% +$126K ﹤0.01% 980
2021
Q1
$7.93M Buy
60,202
+26,959
+81% +$3.69M ﹤0.01% 935
2020
Q4
$4.41M Sell
33,243
-28,633
-46% -$3.46M ﹤0.01% 983
2020
Q3
$6.31M Sell
61,876
-399,386
-87% -$34.5M ﹤0.01% 895
2020
Q2
$40.1M Sell
461,262
-75,875
-14% -$6.06M 0.02% 550
2020
Q1
$31.2M Buy
537,137
+15,796
+3% +$1.28M 0.02% 567
2019
Q4
$48.2M Buy
521,341
+170,576
+49% +$15M 0.02% 607
2019
Q3
$31.7M Buy
350,765
+323,477
+1,185% +$36.9M 0.02% 710
2019
Q2
$3.22M Buy
27,288
+22,101
+426% +$2.23M ﹤0.01% 1104
2019
Q1
$449K Buy
+5,187
New +$442K ﹤0.01% 1250
2018
Q3
Sell
-5,000
Closed -$299K 1457
2018
Q2
$299K Buy
+5,000
New +$269K ﹤0.01% 1335

Other funds holding EXAS

Janus Henderson Group's EXAS Position: Q1 2026 in Review

Janus Henderson Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 84,510 shares — an estimated $8.58M sold.

Janus Henderson Group first reported a position in EXAS in Q2 2018 and held it in 28 quarters. The position peaked at $48.2M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Janus Henderson Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Janus Henderson Group sold 84,510 Exact Sciences shares in Q1 2026, an estimated $8.58M.
  • Janus Henderson Group first reported a position in Exact Sciences in Q2 2018 and held it in 28 quarters.
  • Janus Henderson Group's Exact Sciences position peaked at $48.2M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.